Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating TP53 Wild-Type Chronic Lymphocytic Leukemia.
CANCERS, vol.17, no.2, pp.274-291, 2025 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 17 Issue: 2
- Publication Date: 2025
- Doi Number: 10.3390/cancers17020274
- Journal Name: CANCERS
- Journal Indexes: Scopus, Science Citation Index Expanded (SCI-EXPANDED), Academic Search Premier, BIOSIS, CINAHL, EMBASE, CAB Abstracts, Veterinary Science Database, Directory of Open Access Journals
- Page Numbers: pp.274-291
- Bilecik Şeyh Edebali University Affiliated: Yes